PSMA-Targeted radiopharmaceuticals: from diagnosis to risk & quality of life.

作者信息

Evangelista Laura, Mansi Luigi, Spadafora Marco

机构信息

Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, Pieve Emanuele, Milan, 20072, Italy.

Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, Milan, 20089, Italy.

出版信息

Eur J Nucl Med Mol Imaging. 2025 Aug 8. doi: 10.1007/s00259-025-07507-5.

DOI:10.1007/s00259-025-07507-5

PMID:40779069

Abstract

摘要

相似文献

[1]

PSMA-Targeted radiopharmaceuticals: from diagnosis to risk & quality of life.

Eur J Nucl Med Mol Imaging. 2025-8-8

[2]

Diagnostic Performance of Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography in Patients Diagnosed with Different Types of Breast Cancer: A Systematic Review.

Int J Mol Sci. 2024-10-24

[3]

Comparison of F-based PSMA radiotracers with [Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer-a systematic review and meta-analysis.

Prostate Cancer Prostatic Dis. 2024-12

[4]

Lancet Oncol. 2025-5-26

[5]

The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature.

Minerva Urol Nefrol. 2018-10

[6]

Diagnostic Value of F-FDG and F-PSMA-1007 PET/CT in Bone Metastases from Prostate Cancer: Retrospective Comparative Analysis.

Arch Esp Urol. 2025-6

[7]

Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literature.

Prostate. 2023-7

[8]

Repurposing of PSMA-targeted diagnostic and therapeutic agents for the detection and treatment of giant cell tumors of bone.

Front Oncol. 2024-11-15

[9]

Overview of selected completed prospective studies on PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer.

Nuklearmedizin. 2025-8

[10]

Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysis.

Theranostics. 2025-2-20

本文引用的文献

[1]

Comparison of diagnostic performance between manual diagnosis following PROMISE V2 and aPROMISE utilizing Ga/F-PSMA PET/CT.

Ann Nucl Med. 2025-7-15

[2]

PSMA PET as a Tool for Active Surveillance of Prostate Cancer-Where Are We at?

J Clin Med. 2025-5-20

[3]

The Evolving Role of PSMA-PET/CT in Prostate Cancer Management: an Umbrella Review of Diagnostic Restaging, Therapeutic Redirection, and Survival Impact.

Curr Oncol Rep. 2025-5-14

[4]

Development and evaluation of a bayesian optimization FDG population-based input function for implementing parametric imaging in the clinical practice.

Biomed Phys Eng Express. 2025-5-22

[5]

Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01).

Radiother Oncol. 2025-7

[6]

The Role of PSMA PET Parameters as Biomarkers for Response to PSMA-Targeted Radiopharmaceutical Therapy.

J Nucl Med. 2025-6-2

[7]

Impact of Pelvic Lymph Node Dissection on Early Oncological Outcomes in Intermediate-Risk Prostate Cancer Patients With Node-Negative PSMA PET.

Prostate. 2025-6

[8]

The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update.

Semin Nucl Med. 2025-5

[9]

Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study.

J Nucl Med. 2025-1-3

[10]

High Detection Rates for Prostate-specific Membrane Antigen-avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography.

Eur Urol Open Sci. 2024-12-7

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

PSMA-Targeted radiopharmaceuticals: from diagnosis to risk & quality of life.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

本文引用的文献